| Original language | English (US) |
|---|---|
| Pages (from-to) | 2362-2371 |
| Number of pages | 10 |
| Journal | Journal of the American College of Cardiology |
| Volume | 66 |
| Issue number | 21 |
| DOIs | |
| State | Published - 2015 |
Keywords
- ACC/AHA Scientific Statements
- arrhythmogenic right ventricular cardiomyopathy
- athletes
- cardiomyopathy
- cardiovascular abnormalities
- cardiovascular magnetic resonance
- hypertrophic cardiomyopathy
- myocarditis
- sudden death
ASJC Scopus subject areas
- Cardiology and Cardiovascular Medicine
Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS
Eligibility and Disqualification Recommendations for Competitive Athletes with Cardiovascular Abnormalities : Task Force 3: Hypertrophic Cardiomyopathy, Arrhythmogenic Right Ventricular Cardiomyopathy and Other Cardiomyopathies, and Myocarditis: A Scientific Statement from the American Heart Association and American College of Cardiology. / Maron, Barry J.; Udelson, James E.; Bonow, Robert O.; Nishimura, Rick A.; Ackerman, Michael J.; Estes, N. A.Mark; Cooper, Leslie T.; Link, Mark S.; Maron, Martin S.
In: Journal of the American College of Cardiology, Vol. 66, No. 21, 2015, p. 2362-2371.Research output: Contribution to journal › Article › peer-review
}
TY - JOUR
T1 - Eligibility and Disqualification Recommendations for Competitive Athletes with Cardiovascular Abnormalities
T2 - Task Force 3: Hypertrophic Cardiomyopathy, Arrhythmogenic Right Ventricular Cardiomyopathy and Other Cardiomyopathies, and Myocarditis: A Scientific Statement from the American Heart Association and American College of Cardiology
AU - Maron, Barry J.
AU - Udelson, James E.
AU - Bonow, Robert O.
AU - Nishimura, Rick A.
AU - Ackerman, Michael J.
AU - Estes, N. A.Mark
AU - Cooper, Leslie T.
AU - Link, Mark S.
AU - Maron, Martin S.
N1 - Funding Information: Writing Group Disclosures Writing Group Member Employment Research Grant Other Research Support Speakers Bureau/Honoraria Expert Witness Ownership Interest Consultant/Advisory Board Other Barry J. Maron Minneapolis Heart Institute Foundation None None None None None None None Michael J. Ackerman Mayo Clinic NIH (R01 grants) † None None None None Boston Scientific ∗ ; Gilead Sciences ∗ ; Medtronic ∗ ; St. Jude Medical ∗ Transgenomic † Robert O. Bonow Northwestern University None None None None None None None Leslie T. Cooper, Jr Mayo Clinic None None None None None None None N.A. Mark Estes III Tufts Medical Center None None None None None Medtronic ∗ ; St. Jude Medical † ; Boston Scientific † None Mark S. Link Tufts Medical Center None None None None None None None Martin S. Maron Tufts Medical Center None None None None None None None Rick A. Nishimura Mayo Clinic None None None None None None None James E. Udelson Tufts Medical Center Gilead (DSMB member for a clinical trial) ∗ None None None None None None
PY - 2015
Y1 - 2015
KW - ACC/AHA Scientific Statements
KW - arrhythmogenic right ventricular cardiomyopathy
KW - athletes
KW - cardiomyopathy
KW - cardiovascular abnormalities
KW - cardiovascular magnetic resonance
KW - hypertrophic cardiomyopathy
KW - myocarditis
KW - sudden death
UR - http://www.scopus.com/inward/record.url?scp=84961056921&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84961056921&partnerID=8YFLogxK
U2 - 10.1016/j.jacc.2015.09.035
DO - 10.1016/j.jacc.2015.09.035
M3 - Article
C2 - 26542657
AN - SCOPUS:84961056921
VL - 66
SP - 2362
EP - 2371
JO - Journal of the American College of Cardiology
JF - Journal of the American College of Cardiology
SN - 0735-1097
IS - 21
ER -